# Pharmacokinetic and Bioequivalence Comparison of Baclofen and Chlorzoxazone Administered Individually or Concurrently

> **NCT05257447** · PHASE1 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 19 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** Baclofen 20 mg Tablet
- **DRUG:** Chlorzoxazone 500 mg Tablet
- **DRUG:** Baclofen 20mg tablet and Chlorzoxazone 500 mg tablet

## Key facts

- **NCT ID:** NCT05257447
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-27
- **Primary completion:** 2022-12-13
- **Final completion:** 2022-12-13
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2023-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05257447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05257447, "Pharmacokinetic and Bioequivalence Comparison of Baclofen and Chlorzoxazone Administered Individually or Concurrently". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT05257447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*